Cellectis SA (CLLS)
2.975
+0.04
(+1.54%)
USD |
NASDAQ |
Jun 09, 13:11
Cellectis Total Liabilities (Quarterly) : 229.27M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| DBV Technologies SA | 58.50M |
| Akari Therapeutics Plc | 19.51M |
| Amarin Corp. Plc | 196.35M |
| Grifols SA | 14.09B |
| Autolus Therapeutics Plc | 418.24M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 289.19M |
| Shareholders Equity (Quarterly) | 59.92M |
| Debt to Equity Ratio | 1.812 |
| Current Ratio | 1.521 |
| Net Debt Paydown Yield | 0.07% |